NasdaqCM - Nasdaq Real Time Price USD

Heart Test Laboratories, Inc. (HSCS)

5.83 +0.06 (+1.04%)
At close: June 7 at 4:00 PM EDT
5.57 -0.26 (-4.46%)
After hours: June 7 at 7:56 PM EDT
Loading Chart for HSCS
DELL
  • Previous Close 5.77
  • Open 5.62
  • Bid 5.49 x 100
  • Ask 5.89 x 100
  • Day's Range 5.52 - 5.90
  • 52 Week Range 5.10 - 110.00
  • Volume 33,336
  • Avg. Volume 46,954
  • Market Cap (intraday) 3.822M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -35.00
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 67.50

Heart Test Laboratories, Inc., doing business as HeartSciences, is a medical technology company focuses on applying AI-based technology to an ECG to expand and improve an ECG's clinical utility. It is developing AI-ECG solutions to be made available on a hardware agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is designed to provide diagnostic information related to cardiac dysfunction. The MyoVista also provides conventional ECG information in the same test. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

heartsciences.com

12

Full Time Employees

April 30

Fiscal Year Ends

Recent News: HSCS

Performance Overview: HSCS

Trailing total returns as of 6/7/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HSCS
65.91%
S&P 500
12.10%

1-Year Return

HSCS
94.45%
S&P 500
24.82%

3-Year Return

HSCS
98.17%
S&P 500
45.82%

5-Year Return

HSCS
98.17%
S&P 500
45.82%

Compare To: HSCS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HSCS

Valuation Measures

Annual
As of 6/7/2024
  • Market Cap

    3.82M

  • Enterprise Value

    -2.19M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    66.83

  • Price/Book (mrq)

    0.44

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -52.73%

  • Return on Equity (ttm)

    -152.61%

  • Revenue (ttm)

    18.6k

  • Net Income Avi to Common (ttm)

    -6.39M

  • Diluted EPS (ttm)

    -35.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.08M

  • Total Debt/Equity (mrq)

    12.27%

  • Levered Free Cash Flow (ttm)

    -4.89M

Research Analysis: HSCS

Company Insights: HSCS

Research Reports: HSCS

People Also Watch